Zdrowie i gospodarka · 30/11/2007

FDA Reclassifies Automated Blood Cell Separator Device

The US Food and Drug Administration (FDA) is reclassifying an automated blood cell separator device from Class III to Class II, allowing it to be marketed for routine blood and blood component collection, following new information and the development of special controls.